JP2025512062A5 - - Google Patents
Info
- Publication number
- JP2025512062A5 JP2025512062A5 JP2024560447A JP2024560447A JP2025512062A5 JP 2025512062 A5 JP2025512062 A5 JP 2025512062A5 JP 2024560447 A JP2024560447 A JP 2024560447A JP 2024560447 A JP2024560447 A JP 2024560447A JP 2025512062 A5 JP2025512062 A5 JP 2025512062A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- human
- acid sequence
- protein
- positions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210374811.2 | 2022-04-11 | ||
| CN202210374811 | 2022-04-11 | ||
| PCT/CN2023/086593 WO2023197930A1 (zh) | 2022-04-11 | 2023-04-06 | 补体抑制杂合蛋白 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512062A JP2025512062A (ja) | 2025-04-16 |
| JP2025512062A5 true JP2025512062A5 (enExample) | 2026-04-14 |
Family
ID=88312629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560447A Pending JP2025512062A (ja) | 2022-04-11 | 2023-04-06 | 補体阻害ハイブリッドタンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250257106A1 (enExample) |
| EP (1) | EP4509521A4 (enExample) |
| JP (1) | JP2025512062A (enExample) |
| KR (1) | KR20250004744A (enExample) |
| CN (1) | CN116891533A (enExample) |
| WO (1) | WO2023197930A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024099320A1 (zh) * | 2022-11-10 | 2024-05-16 | 天辰生物医药(苏州)有限公司 | 补体抑制杂合蛋白突变体及其抗体融合蛋白 |
| EP4715959A1 (en) | 2024-02-29 | 2026-03-25 | LG Energy Solution, Ltd. | Method for regenerating cathode active material and regenerated cathode active material manufactured therefrom |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3066699A (en) * | 1998-03-03 | 1999-09-20 | Johns Hopkins University, The | Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation |
| WO2005069726A2 (en) * | 2004-01-21 | 2005-08-04 | Case Western Reserve University | Hybrid and chimeric polypeptides that regulate activation of complement |
| ES2651521T3 (es) * | 2011-12-01 | 2018-01-26 | Innovent Biologics, Inc. | Inhibidores proteicos de las rutas del complemento y de VEGF y métodos de uso de los mismos |
| US9540626B2 (en) * | 2012-03-19 | 2017-01-10 | The Trustees Of The University Of Pennsylvania | Regulator of complement activation and uses thereof |
| CA3029106A1 (en) * | 2016-06-28 | 2018-01-04 | Universitat Ulm | Complement inhibitors and uses thereof |
| GB201706808D0 (en) * | 2017-04-28 | 2017-06-14 | Univ Newcastle | Modified complement proteins and uses thereof |
| EP3586860A1 (en) * | 2018-06-22 | 2020-01-01 | Universität Ulm | Complement inhibitors and uses thereof |
| EP3958901A4 (en) * | 2019-04-24 | 2023-07-19 | The Trustees of the University of Pennsylvania | BI-FUNCTIONAL HUMANIZED ANTI-C5 ANTIBODIES AND H-FACTOR FUSION PROTEINS AND THEIR USES |
| KR20250057830A (ko) * | 2022-08-30 | 2025-04-29 | 롱바이오 파마 (수조우) 컴퍼니 리미티드 | 항-인간 보체 c5 항체 및 이의 융합 단백질 |
-
2023
- 2023-04-06 KR KR1020247037353A patent/KR20250004744A/ko active Pending
- 2023-04-06 WO PCT/CN2023/086593 patent/WO2023197930A1/zh not_active Ceased
- 2023-04-06 JP JP2024560447A patent/JP2025512062A/ja active Pending
- 2023-04-06 US US18/856,041 patent/US20250257106A1/en active Pending
- 2023-04-06 EP EP23787575.2A patent/EP4509521A4/en active Pending
- 2023-04-10 CN CN202310376695.2A patent/CN116891533A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW538049B (en) | A novel human osteoclastogenesis inhibitory factor and a process for preparing the same | |
| JP3860605B2 (ja) | 補体活性化をブロックするキメラタンパク質 | |
| KR960002874B1 (ko) | 재조합된 사람의 내피 세포 성장 인자의 제조방법 | |
| TW302369B (enExample) | ||
| Hemmerich et al. | Structural and functional properties of ribosomal protein L7 from humans and rodents | |
| CA2497857C (en) | Novel p-selectin ligand protein | |
| JP2025512062A5 (enExample) | ||
| EA010741B1 (ru) | ПРИМЕНЕНИЕ ПОЛИПЕПТИДОВ ЦИТОКИНА Zcyto ЧЕЛОВЕКА И МЫШИ И АНТИТЕЛ К ДАННЫМ ПОЛИПЕПТИДАМ ДЛЯ ЛЕЧЕНИЯ РАЗЛИЧНЫХ ЗАБОЛЕВАНИЙ | |
| JPH06506358A (ja) | ナチュラルキラー細胞に特異的なｄｎａおよびアミノ酸配列 | |
| CN105770871A (zh) | IdeS蛋白酶(来自于酿脓链球菌)在自身免疫性疾病和移植排斥的治疗中的用途 | |
| JP2006246890A (ja) | ヒト・インターロイキンー１１受容体 | |
| CA1335360C (en) | Recombinant natural killer cell activator | |
| JPH07508403A (ja) | デコリンフラグメントおよび細胞調節因子を阻害する方法 | |
| JP2597543B2 (ja) | 新規な白血球インターフエロン | |
| EP0412105A1 (en) | Stem cell inhibitors | |
| CN116262781A (zh) | 抗菌肽defensin衍生物及其原核表达方法与应用 | |
| HUP0300999A2 (hu) | CHIPS-aktívitással rendelkező (poli)peptideket kódoló nukleinsavak | |
| HU219762B (hu) | Neisseria meningitidis fertőzések elleni alegység vakcina és a megfelelő tisztított alegységek | |
| JPH07236497A (ja) | インターフェロンにより誘導された蛋白質に対するモノクローナル抗体を生産するハイブリドーマ | |
| CN101232900B (zh) | IdeS蛋白酶(来自于酿脓链球菌)在自身免疫性疾病和移植排斥的治疗中的用途 | |
| MXPA06012321A (es) | Derivados c3 del complemento humano con funcion similar al factor de veneno de cobra. | |
| CA2223503A1 (en) | Transferrin receptor genes | |
| CN104788571B (zh) | 一种靶向性抗肿瘤血管抑制的融合蛋白及其构建方法与应用 | |
| US6893844B1 (en) | DNA encoding a new human hepatoma derived growth factor and producing method thereof | |
| WO2000012717A1 (en) | A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |